| Literature DB >> 36060737 |
Lei Fang1,2, Guankai Lin3, Yi Li3, Qiange Lin3, Huihuang Lou3, Meifeng Lin3, Yuqin Hu3, Airong Xie3, Qinyi Zhang4, Jiancang Zhou1,2, Leyi Zhang3.
Abstract
Increasing human salmonellosis caused by Salmonella enterica serovar Kentucky and London has raised serious concerns. To better understand possible health risks, insights were provided into specific genetic traits and antimicrobial resistance of 88 representative isolates from human and food sources in Zhejiang Province, China, during 2016-2021. Phylogenomic analysis revealed consistent clustering of isolates into the respective serovar or sequence types, and identified plausible interhost transmission via distinct routes. Each serovar exhibited remarkable diversity in host range and disease-causing potential by cgMLST analyses, and approximately half (48.6%, 17/35) of the food isolates were phylogenetically indistinguishable to those of clinical isolates in the same region. S. London and S. Kentucky harbored serovar-specific virulence genes contributing to their functions in pathogenesis. The overall resistance genotypes correlated with 97.7% sensitivity and 60.2% specificity to the identified phenotypes. Resistance to ciprofloxacin, cefazolin, tetracycline, ampicillin, azithromycin, chloramphenicol, as well as multidrug resistance, was common. High-level dual resistance to ciprofloxacin and cephalosporins in S. Kentucky ST198 isolates highlights evolving threats of antibiotic resistance. These findings underscored the necessity for the development of effective strategies to mitigate the risk of food contamination by Salmonella host-restricted serovars.Entities:
Keywords: Salmonella Kentucky; Salmonella London; food safety; multidrug resistance; phylogenomic; whole-genome sequencing
Year: 2022 PMID: 36060737 PMCID: PMC9437622 DOI: 10.3389/fmicb.2022.961739
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1Whole-genome phylogenetic relationships within 88 Salmonella enterica serovar Kentucky (n = 26) and London (n = 62) isolates by cgMLST analysis (~4.5 Mb). The tree was inferred by using the iTOL interactive user interface (https://itol.embl.de). Shading over tip labels indicate sources. Sequence types (STs), including ST155 (n = 62), ST198 (n = 24), and ST314 (n = 2), are annotated by colors and shapes.
Figure 2Distribution of 220 putative virulence genes harbored by Salmonella enterica serovar Kentucky and London isolates in Zhejiang, 2016–2021. The hierarchically clustered circular tree was inferred by using the iTOL interactive user interface (https://itol.embl.de). Shading over tip labels indicate gene functions. Serotypes are annotated by colors and shapes.
Figure 3Genome analysis of putative virulence genes among Salmonella enterica serovar Kentucky and London isolates. (A) Abundance of putative virulence genes identified among different sequence types. Error bars indicate mean with 95% CL. (B) Distribution of putative virulence genes showed discrepancies within 88 Salmonella isolates in the PCA-based prediction model. The blue color in the cell indicates the presence of virulence genes and the white color indicates the corresponding absence of virulence genes. Sequence types and sources are annotated by colors. NS, no significance; ****P < 0.0001.
Antimicrobial resistant rate of Salmonella enterica serovar Kentucky and London isolates against 22 antimicrobials.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
| Penicillin | AMP (≥32) | 88.5 | 64.5 | 54.3 | 83.0 |
| Beta-lactam/beta-lactam inhibitor | AMS (≥32/16) | 53.8 | 37.1 | 51.4 | 52.8 |
| AMC (≥32/16) | 11.5 | 12.9 | 0.0 | 20.8 | |
| Cephalosporins | CFZ (≥8) | 80.7 | 37.1 | 31.4 | 66.0 |
| FEP (≥16) | 26.9 | 6.5 | 5.7 | 17.0 | |
| CTX (≥4) | 61.5 | 8.1 | 17.1 | 28.3 | |
| CFX (≥32) | 11.5 | 6.5 | 0.0 | 13.2 | |
| CAZ (≥16) | 57.7 | 6.5 | 4.0 | 28.3 | |
| Macrolide | AZI (≥32) | 57.7 | 8.1 | 34.3 | 32.1 |
| Carbapenems | IMI (≥4) | 3.8 | 6.5 | 0.0 | 9.4 |
| MEM (≥4) | 3.8 | 4.8 | 0.0 | 7.5 | |
| Aminoglycosides | GEN (≥16) | 76.9 | 56.5 | 54.3 | 67.9 |
| AMI (≥64) | 23.1 | 1.6 | 8.6 | 7.5 | |
| KAN (≥64) | 84.6 | 22.6 | 34.3 | 45.3 | |
| Tetracycline | TET (≥16) | 92.3 | 71.0 | 62.9 | 92.5 |
| DOX (≥16) | 92.3 | 74.2 | 62.9 | 92.5 | |
| MIN (≥16) | 80.8 | 2.7 | 25.8 | 54.7 | |
| Quinolone | CIP (≥1) | 92.3 | 38.7 | 54.3 | 54.7 |
| LEV (≥2) | 88.5 | 11.3 | 34.3 | 34.0 | |
| NAL (≥32) | 92.3 | 16.1 | 34.3 | 41.5 | |
| Phenicol | CHL (≥32) | 80.8 | 67.7 | 62.9 | 77.4 |
| Sulfonamides | SXT (≥4/76) | 69.2 | 56.5 | 51.4 | 66.0 |
Figure 4The number of antimicrobial resistance patterns classified by (A) source and (B) serovar. **P < 0.01.
Genotype and phenotype comparison of Salmonella enterica serovar Kentucky and London isolates from food and humans, 2016 to 2021.
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
| Aminoglycosides | 58 | 0 | 30 | 0 | 100 | 0 |
| Beta-lactam/beta-lactam inhibitor | 63 | 0 | 0 | 25 | 100 | 100 |
| Macrolide | 29 | 0 | 25 | 34 | 100 | 57.6 |
| Phenicol | 63 | 0 | 4 | 21 | 100 | 84.0 |
| Quinolone | 45 | 8 | 10 | 25 | 84.9 | 1.6 |
| Sulfonamides | 53 | 0 | 21 | 14 | 100 | 40.0 |
| Tetracycline | 70 | 1 | 0 | 17 | 98.6 | 100 |
| Total | 381 | 9 | 90 | 136 | 97.7 | 60.2 |